Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPKAPK2 | P49137 | 4/20 | 0.52 |
| ▸ | FLT4 | P35916 | 3/20 | 0.49 |
| ▸ | FES | P07332 | 1/20 | 0.49 |
| ▸ | FGFR1 | P11362 | 1/20 | 0.49 |
| ▸ | KDR | P35968 | 1/20 | 0.49 |
| ▸ | HDAC1 | Q13547 | 6/20 | 0.43 |
| ▸ | ROCK1 | Q13464 | 9/20 | 0.42 |
| ▸ | AURKB | Q96GD4 | 9/20 | 0.42 |
| ▸ | GSK3A | P49840 | 8/20 | 0.42 |
| ▸ | GSK3B | P49841 | 8/20 | 0.42 |
| ▸ | CDC42BPA | Q5VT25 | 8/20 | 0.42 |
| ▸ | CSNK1G3 | Q9Y6M4 | 8/20 | 0.42 |
| ▸ | CHEK2 | O96017 | 7/20 | 0.42 |
| ▸ | PRKACA | P17612 | 7/20 | 0.42 |
| ▸ | RPS6KB1 | P23443 | 7/20 | 0.42 |
| ▸ | RPS6KA3 | P51812 | 7/20 | 0.42 |
| ▸ | PRKG1 | Q13976 | 6/20 | 0.42 |
| ▸ | PKN2 | Q16513 | 6/20 | 0.42 |
| ▸ | HIPK4 | Q8NE63 | 6/20 | 0.42 |
| ▸ | CHEK1 | O14757 | 5/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13046381 | 0.84 | MAPKAPK2 (0.50) | MAPKAPK2FLT4FESFGFR1KDR | |
| SCHEMBL13045646 | 0.84 | MAPKAPK2 (0.50) | MAPKAPK2FLT4FESFGFR1KDR | |
| SCHEMBL13045699 | 0.84 | MAPKAPK2 (0.50) | MAPKAPK2FLT4FESFGFR1KDR | |
| SCHEMBL13045387 | 0.82 | MAPKAPK2 (0.47) | MAPKAPK2FLT4FESFGFR1KDR | |
| SCHEMBL12077886 | 0.80 | MAPKAPK2 (0.50) | MAPKAPK2FLT4FESFGFR1KDR | |
| SCHEMBL4023147 | 0.78 | MAPKAPK2 (0.67) | MAPKAPK2FLT4FESFGFR1KDR | |
| SCHEMBL13045422 | 0.78 | EPHX1 (0.50) | FLT4HDAC1ROCK1ROCK2CYP3A4 | |
| SCHEMBL13047058 | 0.76 | QPCT (0.48) | — | |
| SCHEMBL20095480 | 0.75 | GSK3A (0.55) | MAPKAPK2FLT4FESFGFR1KDR | |
| SCHEMBL13046384 | 0.75 | PRKACA (0.42) | MAPKAPK2FLT4FESFGFR1KDR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20120264755-A1 | PYRIDINYL DERIVATIVES AS INHIBITORS OF ENZYME NICOTINAMIDE PHOSPHORIBOSYLTRANSFERASE | TopoTarget (DE) | 2012-10-18 | — | — | US | claimed |
| EP-2440527-A1 | PYRIDINYL DERIVATIVES AS INHIBITORS OF ENZYME NICOTINAMIDE PHOSPHORIBOSYLTRANSFERASE | Topo Target A/S (DK) | 2012-04-18 | — | — | EP | claimed |
| WO-2010142735-A1 | PYRIDINYL DERIVATIVES AS INHIBITORS OF ENZYME NICOTINAMIDE PHOSPHORIBOSYLTRANSFERASE | TOPOTARGET A/S (DK) | 2010-12-16 | — | — | WO | claimed |
| US-20120264755-A1 | PYRIDINYL DERIVATIVES AS INHIBITORS OF ENZYME NICOTINAMIDE PHOSPHORIBOSYLTRANSFERASE | TopoTarget (DE) | 2012-10-18 | — | — | US | disclosed |
| US-20120264755-A1 | PYRIDINYL DERIVATIVES AS INHIBITORS OF ENZYME NICOTINAMIDE PHOSPHORIBOSYLTRANSFERASE | TopoTarget (DE) | 2012-10-18 | — | — | US | disclosed |
| US-20120264755-A1 | PYRIDINYL DERIVATIVES AS INHIBITORS OF ENZYME NICOTINAMIDE PHOSPHORIBOSYLTRANSFERASE | TopoTarget (DE) | 2012-10-18 | — | — | US | disclosed |
| EP-2440527-A1 | PYRIDINYL DERIVATIVES AS INHIBITORS OF ENZYME NICOTINAMIDE PHOSPHORIBOSYLTRANSFERASE | Topo Target A/S (DK) | 2012-04-18 | — | — | EP | disclosed |
| WO-2010142735-A1 | PYRIDINYL DERIVATIVES AS INHIBITORS OF ENZYME NICOTINAMIDE PHOSPHORIBOSYLTRANSFERASE | TOPOTARGET A/S (DK) | 2010-12-16 | — | — | WO | disclosed |
| WO-2010142735-A1 | PYRIDINYL DERIVATIVES AS INHIBITORS OF ENZYME NICOTINAMIDE PHOSPHORIBOSYLTRANSFERASE | TOPOTARGET A/S (DK) | 2010-12-16 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120264755-A1 | PYRIDINYL DERIVATIVES AS INHIBITORS OF ENZYME NICOTINAMIDE PHOSPHORIBOSYLTRANSFERASE | NAMPT, NAPRT, NNT | MAPKAPK2 2896/4885FLT4 3530/4885FES 1488/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.